Tag Archives: IBB

Top 10 Value Stocks To Own Right Now

New York, NY, based Investment company BlueMountain Capital Management, LLC buys Halcon Resources Corp, Lululemon Athletica Inc, Urban Outfitters Inc, Deckers Outdoor Corp, Activision Blizzard Inc, Sprouts Farmers Market Inc, Vistra Energy Corp, Coca-Cola European Partners PLC, Domino’s Pizza Inc, Nordstrom Inc, sells Bob Evans Farms Inc, C&J Energy Services Inc, Changyou.com, SPDR Dow Jones Industrial Average, SPDR Select Sector Fund – Energy Select Sector during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, BlueMountain Capital Management, LLC. As of 2018-03-31, BlueMountain Capital Management, LLC owns 1149 stocks with a total value of $4.4 billion. These are the details of the buys and sells.

New Purchases: LULU, DECK, SFM, VST, CCE, DPZ, TJX, NAV, TXN, EBAY, Added Positions: HK, URBN, ATVI, JWN, SYY, VAR, TGT, ANET, ENDP, AEO, Reduced Positions: CJ, XLE, ANTM, FB, BBY, CNC, XOM, BA, PF, SPR, Sold Out: BOBE, CYOU, DIA, ESRX, INTU, CLF, ARRS, KORS, F, FLR,

For the details of BlueMountain Capital Management, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=BlueMountain+Capital+Management%2C+LLC

Top 10 Value Stocks To Own Right Now: priceline.com Incorporated(PCLN)

Advisors’ Opinion:

  • [By Jack Delaney]

    For example, owning just one share of The Priceline Group Inc. (Nasdaq: PCLN) would cost $1,921.53. But some of these stocks aren’t quite as “expensive” as they seem…

  • [By Money Morning Staff Reports]

    Through Tom’s various strategies, followers had the chance to pocket gains of 195.36% in 16 days on Priceline Group Inc. (Nasdaq: PCLN), 193.39% in 16 days on SPDR Gold Trust (ETF) (NYSE Arca: GLD), 100% in eight days on International Business Machines Corp. (NYSE: IBM), and even 248.42% in 17 days on SPDR Dow Jones Industrial Average ETF (NYSE Arca: DIA).

  • [By ]

    Will Target (NYSE: TGT) get its mojo back, or will shoppers flock to Walmart (NYSE: WMT)? Which travel agent books more snow ski trips this season, Expedia (Nasdaq: EXPE) or Priceline (Nasdaq: PCLN)? Which video game console emerges on top, Microsoft’s Xbox or Nintendo’s Switch?

Top 10 Value Stocks To Own Right Now: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By ]

    October was not kind to the biggest names in biotech. While smaller, more speculative biotech names consolidated, the big kids fell off a cliff. The biotech slide accelerated midway through the month, with both the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the smaller SPDR S&P Biotech ETF slipping more than 5%.

  • [By Benzinga News Desk]

    After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions: Link

  • [By Jim Crumly]

    Biotech stocks had a big day, with theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) jumping 2.8%. The broad technology sector slipped, and theTechnology Select Sector SPDR ETF (NYSEMKT:XLK)lost 0.1%.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)– which is an exchange-traded fund that holds nearly 200 biotech stocks — has drastically underperformed the S&P 500 over the last three years. That fact suggests that there are bargains to be found in the biotech space.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) a good measure of small-cap biotech stocks gained almost 6% yesterday. Meanwhile, the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) jumped almost 4%. The biotech buying frenzy helped lift the Nasdaq Composite to a gain of almost 1% in Mondays session.

Top 10 Value Stocks To Own Right Now: Nomura Holdings Inc ADR(NMR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Nomura Holdings Inc. (NYSE: NMR) is a Japanese financial services company that provides a variety of financial services to corporations, governments, institutions, and individuals around the world.

Top 10 Value Stocks To Own Right Now: Paychex Inc.(PAYX)

Advisors’ Opinion:

  • [By Max Byerly]

    GW&K Investment Management LLC decreased its holdings in shares of Paychex (NASDAQ:PAYX) by 15.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 509,839 shares of the business services provider’s stock after selling 89,891 shares during the quarter. GW&K Investment Management LLC owned 0.14% of Paychex worth $31,401,000 at the end of the most recent quarter.

  • [By ]

    In the Lightning Round, Cramer was bullish on Paychex (PAYX) , Martin Marietta Materials (MLM) and XPO Logistics (XPO) .

    Cramer was bearish on 3M (MMM) , Fitbit (FIT) and Granite Construction (GVA) .

  • [By Ethan Ryder]

    Schaper Benz & Wise Investment Counsel Inc. WI trimmed its holdings in shares of Paychex (NASDAQ:PAYX) by 2.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 203,575 shares of the business services provider’s stock after selling 6,098 shares during the quarter. Paychex accounts for approximately 1.9% of Schaper Benz & Wise Investment Counsel Inc. WI’s portfolio, making the stock its 24th biggest position. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Paychex were worth $12,538,000 as of its most recent SEC filing.

Top 10 Value Stocks To Own Right Now: Fastenal Company(FAST)

Advisors’ Opinion:

  • [By Jim Crumly]

    As for individual stocks, Fastenal(NASDAQ:FAST) dropped after reporting first-quarter results, and AeroVironment (NASDAQ:AVAV) jumped on an analyst upgrade.

  • [By Garrett Baldwin]

    This morning, President Trump suggested that the United States is considering strong military action in response to recent chemical attacks carried out on civilians by the Syrian government. The president promised to send “nice and new and ‘smart'” missiles to Syria and accused the Russian government of partnering with a “Gas Killing Animal who kills his people and enjoys it!” The president’s remarks are a significant departure from comments made last week, which suggested that the United States would be pulling out of Syria in the coming months. Trump’s threat of war over a recent chemical attack in Syria drove crude oil and gold prices higher. Geopolitical worries often offer a boost to commodity prices due to concerns about supply. Trump’s threat comes at a time that markets are already concerned about a significant military conflict in the Middle East between Saudi Arabia and Iran. WTI crude prices added 0.9% to hit $66.10 per barrel. Brent crude pushed to $71.10 per barrel. Gold price topped $1,350 per ounce and are poised for bigger gains. According to Axios, U.S. Speaker of the House Paul Ryan (R-WI) has privately told friends that he will not seek reelection in the fall. The news comes at a perilous time for Republicans, who are expected to lose the House of Representatives and potentially the Senate. Axios was the first to report the news. The story is also notable because Ryan recently achieved his long-time goal of passing tax reform in late 2017.
    Four Stocks to Watch Today: FB, FOXA, CBS
    Shares of Twenty-First Century Fox Inc.(NYSE: FOXA) fell in pre-market hours on news that investigators from the European Commission raided the firm’s London office yesterday. Reports indicate that investigators are trying to keep their goals confidential. However, there has been a lot of scrutiny over Rupert Murdoch’s goal to purchase rival Sky in recent months. British authorities have argued that this deal would not be in the public’s best interest. Accor

  • [By Joseph Griffin]

    US Bancorp DE cut its stake in Fastenal (NASDAQ:FAST) by 2.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 478,057 shares of the company’s stock after selling 9,751 shares during the quarter. US Bancorp DE owned about 0.17% of Fastenal worth $26,097,000 at the end of the most recent quarter.

Top 10 Value Stocks To Own Right Now: BanColombia S.A.(CIB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Trilogy Global Advisors LP lowered its position in shares of Bancolombia (NYSE:CIB) by 8.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 513,477 shares of the bank’s stock after selling 48,281 shares during the period. Bancolombia comprises about 2.0% of Trilogy Global Advisors LP’s holdings, making the stock its 17th largest holding. Trilogy Global Advisors LP owned approximately 0.21% of Bancolombia worth $21,576,000 at the end of the most recent reporting period.

Top 10 Value Stocks To Own Right Now: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Ezra Schwarzbaum]

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

    Lumentum Holdings Inc (NASDAQ: LITE)
    Ciena Corporation (NYSE: CIEN)
    Coherent, Inc. (NASDAQ: COHR)
    II-VI, Inc. (NASDAQ: IIVI)
    Inphi Corporation (NYSE: IPHI)
    Skyworks Solutions Inc (NASDAQ: SWKS)
    Integrated Device Technology Inc (NASDAQ: IDTI)
    Qorvo Inc (NASDAQ: QRVO)
    Xilinx, Inc. (NASDAQ: XLNX)
    Broadcom Inc (NASDAQ: AVGO)

    Related Links:

  • [By Shane Hupp]

    A number of institutional investors have recently added to or reduced their stakes in the business. Neuberger Berman Group LLC increased its position in Ciena by 169.5% during the third quarter. Neuberger Berman Group LLC now owns 4,217,455 shares of the communications equipment provider’s stock worth $92,657,000 after buying an additional 2,652,791 shares in the last quarter. Millennium Management LLC increased its position in Ciena by 431.6% during the fourth quarter. Millennium Management LLC now owns 2,477,957 shares of the communications equipment provider’s stock worth $51,864,000 after buying an additional 2,011,805 shares in the last quarter. Maverick Capital Ltd. purchased a new position in Ciena during the fourth quarter worth $50,962,000. Renaissance Technologies LLC purchased a new position in Ciena during the fourth quarter worth $40,110,000. Finally, Rubric Capital Management LP purchased a new position in Ciena during the third quarter worth $33,373,000.

    ILLEGAL ACTIVITY WARNING: “Gary B. Smith Sells 8,000 Shares of Ciena (CIEN) Stock” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/3352094/gary-b-smith-sells-8000-shares-of-ciena-cien-stock.html.

    About Ciena

  • [By Ethan Ryder]

    These are some of the headlines that may have effected Accern’s scoring:

    Get Ciena alerts:

    Has the Tide Turned in Boot Barn Holdings, Inc. (BOOT) and Ciena Corporation (CIEN) Stocks? (nmsunews.com) Ciena (CIEN) SVP Sells $50,500.00 in Stock (americanbankingnews.com) Is Ciena Corporation (CIEN) In Search of Flying? (nmsunews.com) Ciena inks deals with Caucasus Online and GlobeNet (telecomlead.com) Ciena’s GeoMesh chosen to enhance submarine networks in Caucasus and Latin America (fibre-systems.com)

    Shares of Ciena stock opened at $25.30 on Friday. Ciena has a 12 month low of $19.40 and a 12 month high of $27.98. The company has a market cap of $3.66 billion, a price-to-earnings ratio of 16.98, a PEG ratio of 1.51 and a beta of 1.40. The company has a quick ratio of 1.79, a current ratio of 2.06 and a debt-to-equity ratio of 0.33.

Top 10 Value Stocks To Own Right Now: Profire Energy, Inc.(PFIE)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors.
    Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading.
    Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday.
    Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday.
    Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday.
    Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading.
    TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday.
    CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading.
    Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading.
    International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday.
    Finisar

Top 10 Value Stocks To Own Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Brian Withers]

    Just when Fitbit (NYSE:FIT) investors were hoping for a glimmer of good news in the company’s fourth quarter earnings report, it seems this wearable device maker’s turnaround has stalled.

  • [By Rick Munarriz]

    Fitbit (NYSE:FIT)has been a meandering mess of an investment over the past two years, but it found a way to be among the market’s biggest winners last week. The leading maker of fitness wristbands saw its shares move 11.48% higher for the week.There was no particularly bullish news out on Fitbit to explain the uptick. The shares are likely just bouncing back after hitting all-time lows a week earlier following a Wall Street downgrade.

  • [By Chris Lange]

    Fitbit, Inc. (NYSE: FIT) reported its most recent quarterly results after markets closed Monday. The company said that it had a net loss of $0.02 per share on $571 million in revenue, compared with consensus estimates from Thomson Reuters that called for breakeven earnings on $588.89 million in revenue. The fourth quarter from last year had a net loss of $0.56 per share on $573.77 million in revenue.

Top 10 Value Stocks To Own Right Now: Atlas Energy, L.P.(ATLS)

Advisors’ Opinion:

  • [By Max Byerly]

    Atlas Energy Group (OTCMKTS: ATLS) and Transglobe Energy (NASDAQ:TGA) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Hot Value Stocks To Own For 2018

Facebook opened more than 8 percent higher a day after reporting better-than-expected first quarter earnings.

Shares opened at $173.22 Thursday after closing Wednesday below $160. That puts Facebook on pace for it’s best day since January 2016.

Facebook beat on both the top and bottom lines, quelling concerns about a diminishing user base and margin compression at least for now.

Facebook has been battling reports of online abuse, government probes and concerns around user privacy.

The company’s stock has lost tens of billions of dollars in shareholder value since initial reports of massive data mishandling by research firm Cambridge Analytica.

Hot Value Stocks To Own For 2018: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)– which is an exchange-traded fund that holds nearly 200 biotech stocks — has drastically underperformed the S&P 500 over the last three years. That fact suggests that there are bargains to be found in the biotech space.

  • [By Benzinga News Desk]

    After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions: Link

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) a good measure of small-cap biotech stocks gained almost 6% yesterday. Meanwhile, the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) jumped almost 4%. The biotech buying frenzy helped lift the Nasdaq Composite to a gain of almost 1% in Mondays session.

  • [By ]

    October was not kind to the biggest names in biotech. While smaller, more speculative biotech names consolidated, the big kids fell off a cliff. The biotech slide accelerated midway through the month, with both the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the smaller SPDR S&P Biotech ETF slipping more than 5%.

  • [By Jim Crumly]

    Biotech stocks had a big day, with theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) jumping 2.8%. The broad technology sector slipped, and theTechnology Select Sector SPDR ETF (NYSEMKT:XLK)lost 0.1%.

Hot Value Stocks To Own For 2018: Sound Financial Bancorp, Inc.(SFBC)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Stilwell Value LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Stilwell+Value+LLC

    These are the top 5 holdings of Stilwell Value LLCOFG Bancorp (OFG) – 1,614,868 shares, 14.1% of the total portfolio. Kingsway Financial Services Inc (KFS) – 3,780,889 shares, 12.63% of the total portfolio. HopFed Bancorp Inc (HFBC) – 627,128 shares, 7.62% of the total portfolio. Alcentra Capital Corp (ABDC) – 1,251,324 shares, 7.27% of the total portfolio. Shares added by 20.66%Sound Financial Bancorp Inc (SFBC) – 228,600 shares, 7.02% of th

Hot Value Stocks To Own For 2018: Reinsurance Group of America, Incorporated(RGA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

  • [By Shane Hupp]

    Westpac Banking Corp grew its holdings in shares of Reinsurance Group of America (NYSE:RGA) by 96.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,188 shares of the insurance provider’s stock after purchasing an additional 4,516 shares during the period. Westpac Banking Corp’s holdings in Reinsurance Group of America were worth $1,415,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment’s rankings:

    Get Reinsurance Group of America alerts:

    Reinsurance Group of America (RGA) versus Its Peers Financial Contrast (americanbankingnews.com) Comparing Reinsurance Group of America (RGA) and The Competition (americanbankingnews.com) Head to Head Analysis: Reinsurance Group of America (RGA) versus Its Competitors (americanbankingnews.com) Reinsurance Group of America (RGA) versus The Competition Financial Survey (americanbankingnews.com) Reinsurance Group of America (RGA) EVP Timothy T. Matson Buys 300 Shares (americanbankingnews.com)

    RGA has been the subject of a number of analyst reports. Wells Fargo restated a “market perform” rating and issued a $160.00 price target (up previously from $150.00) on shares of Reinsurance Group of America in a research report on Tuesday, January 9th. UBS initiated coverage on Reinsurance Group of America in a research report on Friday, March 2nd. They issued a “neutral” rating and a $168.00 price target for the company. Zacks Investment Research cut Reinsurance Group of America from a “buy” rating to a “hold” rating in a research report on Monday, March 12th. Morgan Stanley reduced their price target on Reinsurance Group of America from $138.00 to $135.00 and set an “underweight” rating for the company in a research report on Thursday, April 5th. Finally, Credit Suisse Group initiated coverage on Reinsurance Group of America in a research report on Wednesday, April 25th. They issued a “neutral” rating and a $164.00 price target for the company. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $159.78.

Hot Value Stocks To Own For 2018: Senior Housing Properties Trust(SNH)

Advisors’ Opinion:

  • [By Brian Feroldi, Matthew Frankel, and Dan Caplinger]

    Retirees should favor companies that operate in stable industries and offer their shareholders a predictable stream of income. So which stocks in particular do we think can fulfill their needs? We asked a team of Motley Fool investors to weigh in, and they pickedSenior Housing Properties Trust (NASDAQ:SNH),Prologis(NYSE:PLD), and 3M (NYSE:MMM).

Hot Value Stocks To Own For 2018: Acacia Communications, Inc. (ACIA)

Advisors’ Opinion:

  • [By ]

    Until it’s lifted, the ban stands to impact everyone from optical component/module suppliers such as Acacia Communications (ACIA)  and Oclaro to telecom/networking chip suppliers such as Cavium (CAVM)  and Xilinx (XLNX) to mobile chip suppliers such as Qualcomm (QCOM)  and Skyworks (SWKS) . Some of the damage will, of course, be offset by share losses ZTE is likely to see on account of the ban. This could particularly hold for mobile suppliers, given that the ban could prevent ZTE from shipping phones running Alphabet/Google’s (GOOGL) version of Android.

  • [By Leo Sun]

    That ban would cripple China’s 5G expansion efforts, since ZTE needs components from American companies like Acacia Communications (NASDAQ:ACIA) and Qualcomm. ZTE uses Acacia’s fiber optic components in its infrastructure upgrades, and Qualcomm’s SoCs in its smartphones.

  • [By ]

    Just because the daily rhetoric about trade wars with China is dwindling, it doesn’t mean there aren’t still a lot of companies that could be caught in the crossfire. Cramer said this week’s collapse of Acacia Communications (ACIA) could be the first of many volleys in the escalating trade battle.

  • [By ]

    Investors always need to understand the risks of what they’re buying, Cramer reminded viewers, as he dug into the surprise, but totally foreseeable, 35% decline in shares of Acacia Communications (ACIA) on Monday.

Hot Stocks For 2018

Oil futures ended a four-day string of gains Thursday, with the U.S. benchmark failing to sustain a bounce after data showed a rise in domestic crude-oil inventories.

On the New York Mercantile Exchange, light, sweet crude futures for delivery in February
CLG7, +0.37%
fell 29 cents, or 0.6%, to end at $53.77 a barrel. The contract had traded as high as $54.21 immediately after the Energy Information Administration said crude supplies rose 600,000 barrels last week.

Hot Stocks For 2018: Cross Country Healthcare, Inc.(CCRN)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By ]

    Activist investor Glenn Welling of Engaged Capital LLC, the insurgent investor agitating for changes at TiVo, Rent-a-Center, on Tuesday, May 15, revealed new positions in Aratana Therapeutics Inc. (PETX) , Cross Country Healthcare Inc. (CCRN)  and Finisar Corp. (FNSR)

Hot Stocks For 2018: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) a good measure of small-cap biotech stocks gained almost 6% yesterday. Meanwhile, the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) jumped almost 4%. The biotech buying frenzy helped lift the Nasdaq Composite to a gain of almost 1% in Mondays session.

  • [By Benzinga News Desk]

    After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions: Link

  • [By Jim Crumly]

    Biotech stocks had a big day, with theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) jumping 2.8%. The broad technology sector slipped, and theTechnology Select Sector SPDR ETF (NYSEMKT:XLK)lost 0.1%.

  • [By ]

    October was not kind to the biggest names in biotech. While smaller, more speculative biotech names consolidated, the big kids fell off a cliff. The biotech slide accelerated midway through the month, with both the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the smaller SPDR S&P Biotech ETF slipping more than 5%.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)– which is an exchange-traded fund that holds nearly 200 biotech stocks — has drastically underperformed the S&P 500 over the last three years. That fact suggests that there are bargains to be found in the biotech space.

Hot Stocks For 2018: Glaukos Corporation(GKOS)

Advisors’ Opinion:

  • [By Max Byerly]

    Glaukos Corp (NYSE:GKOS) – Equities research analysts at Piper Jaffray lowered their Q3 2019 EPS estimates for Glaukos in a report released on Wednesday, May 9th. Piper Jaffray analyst M. O’brien now anticipates that the medical instruments supplier will earn $0.02 per share for the quarter, down from their previous forecast of $0.03. Piper Jaffray also issued estimates for Glaukos’ Q4 2019 earnings at $0.02 EPS.

  • [By Shane Hupp]

    Glaukos Corp (NYSE:GKOS) – Equities research analysts at Piper Jaffray lowered their Q3 2019 EPS estimates for Glaukos in a report released on Wednesday, May 9th. Piper Jaffray analyst M. O’brien now anticipates that the medical instruments supplier will earn $0.02 per share for the quarter, down from their previous forecast of $0.03. Piper Jaffray also issued estimates for Glaukos’ Q4 2019 earnings at $0.02 EPS.

  • [By Ethan Ryder]

    Glaukos Corp (NYSE:GKOS) – Equities research analysts at Piper Jaffray lowered their Q3 2019 EPS estimates for Glaukos in a report released on Wednesday, May 9th. Piper Jaffray analyst M. O’brien now anticipates that the medical instruments supplier will earn $0.02 per share for the quarter, down from their previous forecast of $0.03. Piper Jaffray also issued estimates for Glaukos’ Q4 2019 earnings at $0.02 EPS.

Best Stocks For 2019

If you’re itching to start investing in the stock market, who could blame you? It’s where Warren Buffett and countless others have made much of their money, and it’s just about the best way to build wealth over the long term. But hold your horses: First use these six questions as a checklist to make sure you can afford to invest.

Image source: Getty Images.

1. Do you have $25 or more?

Let’s start with an easy question. Do you have some extra dollars? You might think you need a lot, as a single share of Warren Buffett’s company Berkshire Hathaway recently cost $162 — or $243,000! — depending on the class of shares. Amazon.com shares, meanwhile, were recently near $800 a pop, while Priceline Group shares topped $1,500 each. Gobs of companies trade at much lower stock prices, though — often below $100.

Best Stocks For 2019: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

Best Stocks For 2019: Waste Management, Inc.(WM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By ]

    For his “Executive Decision” segment, Cramer spoke with Jim Fish, president and CEO of Waste Management (WM) , which just posted an eight-cents-a-share earnings beat, but saw shares decline as investors worry over the impact of trade wars with China on the company’s recycling business.

  • [By Brian Feroldi]

    Investors in their 60’s should start to favor low-risk stocks that offer up big dividend payouts. Below are three stocks — Waste Management (NYSE:WM), United Parcel Service (NYSE:UPS), and Welltower (NYSE:HCN) — that perfectly fit that description.

  • [By ]

    For his “Executive Decision” segment, Cramer spoke with Jim Fish, president and CEO of Waste Management (WM) , which just posted an eight-cents-a-share earnings beat, but saw shares decline as investors worry over the impact of trade wars with China on the company’s recycling business.

Best Stocks For 2019: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By Ben Levisohn]

    Biotech stocks are having a great day today–iShares Nasdaq Biotechnology ETF (IBB) has climbed 2.5% to $276.92–leading some to suggest that 2017 could be better for investors than 2016 was. Not Baird’s Brian Skorney and Michael Ulz, who “don’t think 2017 will be worse than 2016″ but “aren’t quite sure it will be much better.” They explain why:

    Agence France-Presse/Getty Images

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

    A steadily building pharma cash war chest is a big offsetting tailwind. As Princess Leia would say, “Help me M&A, you’re my only hope.”

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By WWW.THESTREET.COM]

    Biotechnology stocks had an incredible run between 2012 and 2015, and the iShares Nasdaq Biotechnology ETF (IBB) was up 395% in that time. After making the record high, however, the space came under pressure and the fund dropped below its 40-week moving average, eventually retracing 50% of its historic rally before finding support in the $240.00 area. Since that time, it has been moving in a horizontal channel below the 38% retracement level of the pullback range in the $300.00 area, and 2016 triple-bottom support.

  • [By Ben Levisohn]

    Shares of Amgen have dropped 0.8% to $146.61 at 2:44 p.m. today, while Regeneron Pharmaceutical has fallen 0.5% to $369.83, and Celgene has gained 2% to $118.10. The iShares Nasdaq Biotechnology ETF (IBB) has risen 0.4% to $269.86.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) a good measure of small-cap biotech stocks gained almost 6% yesterday. Meanwhile, the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) jumped almost 4%. The biotech buying frenzy helped lift the Nasdaq Composite to a gain of almost 1% in Mondays session.

  • [By ]

    October was not kind to the biggest names in biotech. While smaller, more speculative biotech names consolidated, the big kids fell off a cliff. The biotech slide accelerated midway through the month, with both the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the smaller SPDR S&P Biotech ETF slipping more than 5%.

Top Warren Buffett Stocks To Buy For 2018

Sometimes identifying the best stocks to buy can be difficult, but you could do a lot worse than check out the stocks selected by one of the world’s wealthiest hedge fund managers — George Soros.

Self-made Soros fled Hungary and funded his way through an economics degree by working as a railway porter and waiter. Years of successful investing gave him a net worth of $25.2 billion and the no. 1 ranking on Forbes’ hedge fund manager rich list. (Warren Buffett, who has a whopping $75 billion net worth, wins the no.1 title for the wider finance and investments community). In 1992, Soros shorted the British pound and reportedly made a profit of $1 billion. He became known as the man who broke the Bank of England.

Now we can track the latest trades of his family office, Soros Fund Management. Just-released SEC forms reveal a valuable glimpse into which stocks Soros likes, and which he doesn’t. I looked back over 2017 and pinpointed Soros’ best stock picks this year. These are the stocks that this legendary hedge fund manager is most bullish on. Note that Soros has just shifted an incredible $18 billion from the fund to charity. Following the move, the fund manages about $4 billion in portfolio assets.

Top Warren Buffett Stocks To Buy For 2018: Orchid Island Capital, Inc.(ORC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Orchid Island Capital Inc. (NYSE: ORC) fell about 9.7% to post a new 52-week low of $7.85 Thursday after closing at $8.69 on Wednesday. The 52-week high is $12.60. Volume of about 5.2 million was nearly 5 times the daily average of around 1.1 million. The company lowered its monthly dividend by 3 cents last night.

Top Warren Buffett Stocks To Buy For 2018: The Rubicon Project, Inc.(RUBI)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Rubicon Project Inc. (NYSE: RUBI) dropped about 2.4% on Tuesday to post a new 52-week low of $8.64 against a 52-week high of $20.37. Volume of around 680,000 million was about 15% below the daily average of around 780,000. The stock closed at $8.85 on Monday night. The ad marketplace has formed a strategic alliance with Flipboard that will allow advertisers to buy ad space on Flipboard.

  • [By Paul Ausick]

    Rubicon Project Inc. (NYSE: RUBI) dropped about 1.9% Friday, to post a new 52-week low of $5.65 after closing at $5.76 on Thursday. The stock’s 52-week high is $20.37. Volume was nearly 4 times the daily average of around 740,000 shares. The company had no specific news.

  • [By Paul Ausick]

    Rubicon Project Inc. (NYSE: RUBI) dropped about 29% Wednesday to post a new 52-week low of $5.96 after closing Tuesday at $8.39. Volume of more than 6.1 million shares was more than 10 times the daily average of less than 600,000. The company named a new CEO and reported weak results after markets closed Tuesday.

Top Warren Buffett Stocks To Buy For 2018: NO Name(ACI)

Advisors’ Opinion:

  • [By Robert Weinstein]

    Lawsuit after lawsuit, a billion dollars in cost overruns, taxpayer subsidies and the most expensive coal plant to operate causing electric rates to skyrocket, if this becomes the norm. The new project is called Plant Ratcliffe by Southern Co.
    Plant Ratcliffe is quite the boondoggle, but proponents say it always costs more to build the first one and costs will come down as the technology improves. More plants are in the planning stages and may bring a needed shot in the arm to mining stocks.
    Alpha Natural Resources (ANR), Walter Energy (WLT), Arch Coal (ACI), Cliffs Natural Resources (CLF), Peabody Energy (BTU), and James River Coal (JRCC) are companies that may benefit from increased demand for coal.
    Not all coal or coal companies are equal, so it’s crucial to discriminate based on your investment time-horizon goals. With that said, the announcement should have been followed by a deep sell-off in coal and utility related stocks. But something happened.
    Or, rather, didn’t happen.
    The above coal stocks didn’t sell off tremendously and are largely moving along with the rest of the market today. This is noteworthy because stocks don’t bottom on good news, they reach a bottom on awful news. Let me explain: When a stock chart continues trending lower, what you’re witnessing is investors throwing in the towel and moving on.
    Leaving aside bankruptcies for a moment, almost all stocks have a core group of investors that are commonly known as the “strong hands.” A stock is at the bottom when the weak hands are gone. At some point, distressing news (like an unfavorable EPA announcement regarding coal) hits the wire and the related stock or stocks react with little or no movement. This is what we are witnessing right now in coal-related companies.

Top Warren Buffett Stocks To Buy For 2018: V.F. Corporation(VFC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

  • [By Leo Sun]

    VF Corp. (NYSE:VFC) owns a massive portfolio of apparel companies, including The North Face, Timberland, Wrangler, Lee, and Vans. It’s raised its dividend annually for over four decades — making it an elite “dividend aristocrat” which has boosted its payout for at least 25 straight years. VF currently pays a forward yield of 3.1%, which is supported by a payout ratio of 55%. The stock trades at 21 times earnings.

  • [By Jeremy Bowman]

    The North Face, in particular, seems like a cautionary tale. The outdoor gear and apparel maker had its IPO in 1996. By 1999 sales were falling and the company put up a $100 million loss. In 2000,VF Corporation(NYSE:VFC) acquired it for just $25.4 million, despite $238 million in sales and a once-popular brand. Today, under the guidance of VF Corp, The North Face now has more than $2 billion in annual sales.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Top Warren Buffett Stocks To Buy For 2018: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Craig Jones]

    Guy Adami believes that iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) is a Buy. He explained that it held well in a tough trading session for the rest of the market.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

  • [By Ben Levisohn]

    Endo International slumped 8.6% to $14.00 today, while the S&P 500 rose 0.3% to 2,275.32. The iShares Nasdaq Biotechnology (IBB) fell 3% to $277.94, while the SPDR S&P Pharmaceuticals ETF (XPH) dropped 2.9% to $39.41.

  • [By Ben Levisohn]

    Shares of Amgen have dropped 0.8% to $146.61 at 2:44 p.m. today, while Regeneron Pharmaceutical has fallen 0.5% to $369.83, and Celgene has gained 2% to $118.10. The iShares Nasdaq Biotechnology ETF (IBB) has risen 0.4% to $269.86.